Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zandberg

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Journal of Cancer Survivorship : Research and Practice|September 7, 2025
Clinical and social determinants of survivorship clinic attendance in head and neck cancerMaryanna S Owoc, Katie M Carlson, Marci Lee Nilsen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 23, 2024
Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma PatientsRonan W Hsieh, William E Gooding, Marci Nilsen, et al.
Contemporary Clinical Trials|February 8, 2021
The next generation of collaborative care: The design of a novel web-based stepped collaborative care intervention delivered via telemedicine for people diagnosed with cancerJennifer L Steel, Vincent Reyes, Dan P Zandberg, et al.
Head & Neck|July 31, 2024
Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patientsDan P Zandberg, Serafettin Zenkin, Murat Ak, et al.
Oral Oncology|December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion studyRenata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.
Head & Neck|December 10, 2014
Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer CenterDan P Zandberg, Sandy Liu, Olga Goloubeva, et al.
Head & Neck|April 14, 2026
Social Determinants of Health and Patient-Reported Outcome Measures Among Head and Neck Cancer SurvivorsFendi Obuekwe, Jinhong Li, Stephen Glass, et al.
Oral Oncology|March 24, 2023
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neckNicole N Scheff, Marci L Nilsen, Jinhong Li, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 25, 2024
The interdependence of depressive symptoms and sleep in dyads affected by cancerGeorge N Diamantis, Youngmee Kim, Zoe Ofori-Atta, et al.
Journal of Cancer Survivorship : Research and Practice|February 20, 2026
Clinical and social determinants of sustained head and neck cancer survivorship clinic attendanceKatie M Carlson, Maryanna S Owoc, Marci Lee Nilsen, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Journal of Cancer Survivorship : Research and Practice|September 7, 2025
Clinical and social determinants of survivorship clinic attendance in head and neck cancerMaryanna S Owoc, Katie M Carlson, Marci Lee Nilsen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 23, 2024
Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma PatientsRonan W Hsieh, William E Gooding, Marci Nilsen, et al.
Contemporary Clinical Trials|February 8, 2021
The next generation of collaborative care: The design of a novel web-based stepped collaborative care intervention delivered via telemedicine for people diagnosed with cancerJennifer L Steel, Vincent Reyes, Dan P Zandberg, et al.
Head & Neck|July 31, 2024
Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patientsDan P Zandberg, Serafettin Zenkin, Murat Ak, et al.
Oral Oncology|December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion studyRenata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.
Head & Neck|December 10, 2014
Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer CenterDan P Zandberg, Sandy Liu, Olga Goloubeva, et al.
Head & Neck|April 14, 2026
Social Determinants of Health and Patient-Reported Outcome Measures Among Head and Neck Cancer SurvivorsFendi Obuekwe, Jinhong Li, Stephen Glass, et al.
Oral Oncology|March 24, 2023
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neckNicole N Scheff, Marci L Nilsen, Jinhong Li, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 25, 2024
The interdependence of depressive symptoms and sleep in dyads affected by cancerGeorge N Diamantis, Youngmee Kim, Zoe Ofori-Atta, et al.
Journal of Cancer Survivorship : Research and Practice|February 20, 2026
Clinical and social determinants of sustained head and neck cancer survivorship clinic attendanceKatie M Carlson, Maryanna S Owoc, Marci Lee Nilsen, et al.
Pageof 10